MedTrace Logo

Understanding Magnetic Resonance Imaging in Multiple Sclerosis

NCT03872583 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2024-01-03

No results posted yet for this study

Summary

Magnetic resonance imaging (MRI) results play a major role in the lives of people with multiple sclerosis (pwMS). Even though MRI is used for diagnosis, prognosis and therapy control, pwMS' knowledge concerning this complex matter is scarce. Without adequate disease-specific knowledge, pwMS cannot truly make an informed choice when considering their MRI results (e.g. necessity of future MRI scans or therapy change).

The investigators have developed an innovative, evidence-based and interactive online education tool called "Understanding MRI in MS", which incorporates all relevant information about MRI in MS and its implications in disease management.

In this randomized, controlled and double-blind trial the tool's effect on MRI-specific knowledge, self-perceived competence and involvement in medical decision, that are based on MRI results will be assessed.

Conditions

Interventions

OTHER

Understanding MRI in MS (website)

Access to an innovative, interactive and evidence-based online education tool about MRI in multiple sclerosis.

OTHER

Control website

Access to a specifically designed control website containing information on MRI in MS freely available on the websites of major European MS self-help organizations.

Sponsors & Collaborators

  • Sanofi

    collaborator INDUSTRY

  • Universitätsklinikum Hamburg-Eppendorf

    lead OTHER

Principal Investigators

  • Christoph Heesen, Prof. · University Medical Center Hamburg-Eppendorf; Institute for Neuroimmunology and Multiple Sclerosis

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-15
Primary Completion
2022-12-01
Completion
2022-12-01

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03872583 on ClinicalTrials.gov